Month: September 2020

Chartwell Partners is pleased to announce the recruitment of Nick Harvey as Chief Financial Officer for Adicet Bio, a public biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Mr. Harvey joins Adicet most recently from Centrexion Therapeutics, a privately held biotechnology company, where he served as Executive…